Full Text
EE213 Cost-Effectiveness Analysis of Oral Semaglutide As a Third-Line Treatment for Patients With Type 2 Diabetes Mellitus

Abstract

Authors

Ruen Yi (Ella) Chen Audrey Lee Jonathan Wu Elise Chia Hui Tan

Back to Volume 28, Supplemental Issue 12S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×